Drug makers face tougher rules on human placenta drugs

Published: 2006-07-11 06:57:00
Updated: 2006-07-11 06:57:00
The Korea Food and Drug Administration (KFDA) said it will tighten rules on a human placenta drug as part of efforts to ensure its safety and efficacy.

To bring the finished placenta products by pharmaceutical firms under closer scrutiny, they will be produced using virus-free placenta bulk ma...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.